
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SARS‐CoV‐2 and Mitochondrial Proteins in Neural‐Derived Exosomes of COVID‐19
Michael J. Peluso, Steven G. Deeks, Maja Mustapić, et al.
Annals of Neurology (2022) Vol. 91, Iss. 6, pp. 772-781
Open Access | Times Cited: 98
Michael J. Peluso, Steven G. Deeks, Maja Mustapić, et al.
Annals of Neurology (2022) Vol. 91, Iss. 6, pp. 772-781
Open Access | Times Cited: 98
Showing 1-25 of 98 citing articles:
Long COVID: major findings, mechanisms and recommendations
Hannah Davis, Lisa McCorkell, Julia Moore Vogel, et al.
Nature Reviews Microbiology (2023) Vol. 21, Iss. 3, pp. 133-146
Open Access | Times Cited: 2592
Hannah Davis, Lisa McCorkell, Julia Moore Vogel, et al.
Nature Reviews Microbiology (2023) Vol. 21, Iss. 3, pp. 133-146
Open Access | Times Cited: 2592
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)
Amy D. Proal, Michael B. VanElzakker, Soo Aleman, et al.
Nature Immunology (2023) Vol. 24, Iss. 10, pp. 1616-1627
Open Access | Times Cited: 171
Amy D. Proal, Michael B. VanElzakker, Soo Aleman, et al.
Nature Immunology (2023) Vol. 24, Iss. 10, pp. 1616-1627
Open Access | Times Cited: 171
Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches
Jasimuddin Ahamed, Jeffrey Laurence
Journal of Clinical Investigation (2022) Vol. 132, Iss. 15
Open Access | Times Cited: 102
Jasimuddin Ahamed, Jeffrey Laurence
Journal of Clinical Investigation (2022) Vol. 132, Iss. 15
Open Access | Times Cited: 102
Cellular and molecular biomarkers of long COVID: a scoping review
Estefanía Espín, Chengliang Yang, Casey P. Shannon, et al.
EBioMedicine (2023) Vol. 91, pp. 104552-104552
Open Access | Times Cited: 62
Estefanía Espín, Chengliang Yang, Casey P. Shannon, et al.
EBioMedicine (2023) Vol. 91, pp. 104552-104552
Open Access | Times Cited: 62
Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative
Hector Bonilla, Michael J. Peluso, Kathleen E. Rodgers, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 58
Hector Bonilla, Michael J. Peluso, Kathleen E. Rodgers, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 58
The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID
Jingwei Li, Yun Zhou, Jiechao Ma, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 57
Jingwei Li, Yun Zhou, Jiechao Ma, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 57
Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2
Kailin Yin, Michael J. Peluso, Xiaoyu Luo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 47
Kailin Yin, Michael J. Peluso, Xiaoyu Luo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 47
SARS-CoV-2 and innate immunity: the good, the bad, and the “goldilocks”
Benjamín L. Sievers, Mark T. K. Cheng, Kata Csiba, et al.
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 171-183
Open Access | Times Cited: 44
Benjamín L. Sievers, Mark T. K. Cheng, Kata Csiba, et al.
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 171-183
Open Access | Times Cited: 44
Possible Pathogenesis and Prevention of Long COVID: SARS-CoV-2-Induced Mitochondrial Disorder
Tsung‐Hsien Chen, Chia-Jung Chang, Peir‐Haur Hung
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8034-8034
Open Access | Times Cited: 40
Tsung‐Hsien Chen, Chia-Jung Chang, Peir‐Haur Hung
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8034-8034
Open Access | Times Cited: 40
Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection
Michael J. Peluso, Dylan Ryder, Robert R. Flavell, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 754
Open Access | Times Cited: 34
Michael J. Peluso, Dylan Ryder, Robert R. Flavell, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 754
Open Access | Times Cited: 34
Association of nirmatrelvir for acute SARS‐CoV‐2 infection with subsequent Long COVID symptoms in an observational cohort study
Matthew S. Durstenfeld, Michael J. Peluso, Feng Lin, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 1
Open Access | Times Cited: 27
Matthew S. Durstenfeld, Michael J. Peluso, Feng Lin, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 1
Open Access | Times Cited: 27
Mechanisms of long COVID and the path toward therapeutics
Michael J. Peluso, Steven G. Deeks
Cell (2024)
Open Access | Times Cited: 23
Michael J. Peluso, Steven G. Deeks
Cell (2024)
Open Access | Times Cited: 23
Neuroinflammation in post-acute sequelae of COVID-19 (PASC) as assessed by [11C]PBR28 PET correlates with vascular disease measures
Michael B. VanElzakker, Hannah F. Bues, Ludovica Brusaferri, et al.
Brain Behavior and Immunity (2024) Vol. 119, pp. 713-723
Open Access | Times Cited: 16
Michael B. VanElzakker, Hannah F. Bues, Ludovica Brusaferri, et al.
Brain Behavior and Immunity (2024) Vol. 119, pp. 713-723
Open Access | Times Cited: 16
Effect of Oral Nirmatrelvir on Long COVID Symptoms: 4 Cases and Rationale for Systematic Studies
Michael J. Peluso, Khamal Anglin, Matthew S. Durstenfeld, et al.
Pathogens and Immunity (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 50
Michael J. Peluso, Khamal Anglin, Matthew S. Durstenfeld, et al.
Pathogens and Immunity (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 50
Long COVID brain fog and muscle pain are associated with longer time to clearance of SARS-CoV-2 RNA from the upper respiratory tract during acute infection
Annukka A.R. Antar, Tong Yu, Zoe O Demko, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 35
Annukka A.R. Antar, Tong Yu, Zoe O Demko, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 35
Multimodal Molecular Imaging Reveals Tissue-Based T Cell Activation and Viral RNA Persistence for Up to 2 Years Following COVID-19
Michael J. Peluso, Dylan Ryder, Robert R. Flavell, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 35
Michael J. Peluso, Dylan Ryder, Robert R. Flavell, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 35
Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges
Dimitrios Tsilingiris, Natalia G. Vallianou, Ιrene Karampela, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10458-10458
Open Access | Times Cited: 30
Dimitrios Tsilingiris, Natalia G. Vallianou, Ιrene Karampela, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10458-10458
Open Access | Times Cited: 30
COVID-19 and Long COVID: Disruption of the Neurovascular Unit, Blood-Brain Barrier, and Tight Junctions
Duraisamy Kempuraj, Kristina Aenlle, Jessica R. Cohen, et al.
The Neuroscientist (2023) Vol. 30, Iss. 4, pp. 421-439
Closed Access | Times Cited: 28
Duraisamy Kempuraj, Kristina Aenlle, Jessica R. Cohen, et al.
The Neuroscientist (2023) Vol. 30, Iss. 4, pp. 421-439
Closed Access | Times Cited: 28
Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design
Leora I. Horwitz, Tanayott Thaweethai, Shari B. Brosnahan, et al.
PLoS ONE (2023) Vol. 18, Iss. 6, pp. e0286297-e0286297
Open Access | Times Cited: 24
Leora I. Horwitz, Tanayott Thaweethai, Shari B. Brosnahan, et al.
PLoS ONE (2023) Vol. 18, Iss. 6, pp. e0286297-e0286297
Open Access | Times Cited: 24
A comprehensive SARS-CoV-2 and COVID-19 review, Part 2: host extracellular to systemic effects of SARS-CoV-2 infection
S Narayanan, David A. Jamison, Joseph W. Guarnieri, et al.
European Journal of Human Genetics (2023) Vol. 32, Iss. 1, pp. 10-20
Open Access | Times Cited: 24
S Narayanan, David A. Jamison, Joseph W. Guarnieri, et al.
European Journal of Human Genetics (2023) Vol. 32, Iss. 1, pp. 10-20
Open Access | Times Cited: 24
Inflammation in the COVID-19 airway is due to inhibition of CFTR signaling by the SARS-CoV-2 spike protein
H. Caohuy, Ofer Eidelman, Tinghua Chen, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
H. Caohuy, Ofer Eidelman, Tinghua Chen, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Early biological markers of post-acute sequelae of SARS-CoV-2 infection
Scott Lu, Michael J. Peluso, David V. Glidden, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Scott Lu, Michael J. Peluso, David V. Glidden, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Cardiovascular effects of the post-COVID-19 condition
Erin Goerlich, Tae Hwan Chung, Gloria Hong, et al.
Nature Cardiovascular Research (2024) Vol. 3, Iss. 2, pp. 118-129
Open Access | Times Cited: 7
Erin Goerlich, Tae Hwan Chung, Gloria Hong, et al.
Nature Cardiovascular Research (2024) Vol. 3, Iss. 2, pp. 118-129
Open Access | Times Cited: 7
SARS-CoV-2 post-acute sequelae in previously hospitalised patients: systematic literature review and meta-analysis
J. Daniel Kelly, Tristan Curteis, Aaditya Rawal, et al.
European Respiratory Review (2023) Vol. 32, Iss. 169, pp. 220254-220254
Open Access | Times Cited: 20
J. Daniel Kelly, Tristan Curteis, Aaditya Rawal, et al.
European Respiratory Review (2023) Vol. 32, Iss. 169, pp. 220254-220254
Open Access | Times Cited: 20
Long Covid
Asiya Kamber Zaidi, Puya Dehgani‐Mobaraki
Progress in molecular biology and translational science (2024)
Closed Access | Times Cited: 5
Asiya Kamber Zaidi, Puya Dehgani‐Mobaraki
Progress in molecular biology and translational science (2024)
Closed Access | Times Cited: 5